AKT1 and hepatocellular carcinoma: Exosomes from two aggressive HCC cell lines were able to provoke sorafenib resistance in vitro by stimulating the hepatocyte growth factor/c-Met/Akt pathway and reducing sorafenib-caused programmed cell death [103].